Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review

Myriam Drysdale, Daniel C. Gibbons, Moushmi Singh, Catherine Rolland, Louis Lavoie, Andrew Skingsley, Emily J. Lloyd
doi: https://doi.org/10.1101/2023.03.09.23287034

Article usage

Article usage: March 2023 to December 2024

AbstractFullPdf
Mar 202312389184
Apr 2023142125
May 202362116
Jun 20238457
Jul 202338113
Aug 202348129
Sep 2023581020
Oct 202342510
Nov 202340516
Dec 202330011
Jan 20242339
Feb 20243332
Mar 202435510
Apr 20241936
May 20242323
Jun 202424613
Jul 202429517
Aug 20243434
Sep 2024311410
Oct 202414215
Nov 20242124
Dec 20241013
Back to top
Posted March 10, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review
Myriam Drysdale, Daniel C. Gibbons, Moushmi Singh, Catherine Rolland, Louis Lavoie, Andrew Skingsley, Emily J. Lloyd
medRxiv 2023.03.09.23287034; doi: https://doi.org/10.1101/2023.03.09.23287034
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area